Opko Health Inc (OPK) concluded trading on Thursday at a closing price of $1.63, with 4.78 million shares of worth about $7.79 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 0.62% during that period and on February 27, 2025 the price saw a loss of about -1.81%. Currently the company’s common shares owned by public are about 682.48M shares, out of which, 308.55M shares are available for trading.
Stock saw a price change of -2.40% in past 5 days and over the past one month there was a price change of 8.67%. Year-to-date (YTD), OPK shares are showing a performance of 10.88% which increased to 63.57% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.86 but also hit the highest price of $1.76 during that period. The average intraday trading volume for Opko Health Inc shares is 3.31 million. The stock is currently trading 0.09% above its 20-day simple moving average (SMA20), while that difference is up 4.93% for SMA50 and it goes to 9.90% higher than SMA200.
Opko Health Inc (NASDAQ: OPK) currently have 682.48M outstanding shares and institutions hold larger chunk of about 30.91% of that.
The stock has a current market capitalization of $1.11B and its 3Y-monthly beta is at 1.72. It has posted earnings per share of -$0.19 in the same period. It has Quick Ratio of 2.69 while making debt-to-equity ratio of 0.37. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for OPK, volatility over the week remained 4.44% while standing at 3.69% over the month.
Stock’s fiscal year EPS is expected to drop by -266.67% while it is estimated to increase by 57.95% in next year. EPS is likely to grow at an annualized rate of 4.35% for next 5-years, compared to annual growth of 1.56% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Barrington Research on June 29, 2023 offering an Outperform rating for the stock and assigned a target price of $2 to it. Coverage by H.C. Wainwright stated Opko Health Inc (OPK) stock as a Buy in their note to investors on December 15, 2022, suggesting a price target of $3 for the stock. On January 24, 2022, Barrington Research Downgrade their recommendations, while on June 21, 2021, Ladenburg Thalmann Initiated their ratings for the stock with a price target of $7. Stock get an Overweight rating from Piper Jaffray on November 25, 2019.
